CID 509953

Schembl7482849

Structural Information

Molecular Formula
C30H41N5OS
SMILES
CC(C)C1=CC(=C(C(=C1)C(C)C)C(=O)NC2=NN=C(S2)NC3CCN(CC3)CC4=CC=CC=C4)C(C)C
InChI
InChI=1S/C30H41N5OS/c1-19(2)23-16-25(20(3)4)27(26(17-23)21(5)6)28(36)32-30-34-33-29(37-30)31-24-12-14-35(15-13-24)18-22-10-8-7-9-11-22/h7-11,16-17,19-21,24H,12-15,18H2,1-6H3,(H,31,33)(H,32,34,36)
InChIKey
ABXXJOLJEJHDEE-UHFFFAOYSA-N
Compound name
N-[5-[(1-benzylpiperidin-4-yl)amino]-1,3,4-thiadiazol-2-yl]-2,4,6-tri(propan-2-yl)benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

519.30316 Da
Monoisotopic Mass

7.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 520.31044 227.5
[M+Na]+ 542.29238 228.5
[M-H]- 518.29588 235.2
[M+NH4]+ 537.33698 230.7
[M+K]+ 558.26632 222.0
[M+H-H2O]+ 502.30042 216.1
[M+HCOO]- 564.30136 235.3
[M+CH3COO]- 578.31701 253.0
[M+Na-2H]- 540.27783 219.2
[M]+ 519.30261 226.6
[M]- 519.30371 226.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe